Compare iShares S&P GSCI Commodity-Indexed Trust ETF (GSG) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares S&P GSCI Commodity-Indexed Trust ETF vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? iShares S&P GSCI Commodity-Indexed Trust ETF trades at $36.05 (market cap $1.02B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.57 (market cap $6.04B). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 5.9× iShares S&P GSCI Commodity-Indexed Trust ETF's market cap, and Iovance Biotherapeutics Inc. Common Stock is more actively traded (14,805,993 versus 1,256,221). Which is the better fit depends on your goals — on Pluang, investors hold iShares S&P GSCI Commodity-Indexed Trust ETF for 41 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| GSG | IOVA | |
|---|---|---|
Market Cap | $1.02B | $6.04B |
Volume | 1,256,221 | 14,805,993 |
Sector | Commodities - Metals/Agriculture | Health |
52-Week High | $37.15 | $14.82 |
52-Week Low | $22.45 | $1.81 |
Typical Hold Time | 41 Days | 0 Days |
Enterprise Value | — | $5.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares S&P GSCI Commodity-Indexed Trust ETF
GSG is a diversified commodity ETF that tracks the S&P GSCI Total Return Index. It provides exposure to a broad basket of futures, including energy, metals, and agriculture, with a significant weighting toward the energy sector.
Read more on GSG →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
